AI Verdict
FAMI has stronger fundamentals based on our AI analysis.
FATE vs FAMI Fundamental Comparison
| Metric | FATE | FAMI |
|---|---|---|
| Revenue | $6.6M | N/A |
| Net Income | $-136.3M | N/A |
| Net Margin | -2,051.1% | N/A |
| ROE | -65.8% | N/A |
| ROA | -42.7% | N/A |
| Current Ratio | 5.79x | N/A |
| Debt/Equity | 0.07x | N/A |
| EPS | $-1.15 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
FATE vs FAMI: Frequently Asked Questions
Is FATE or FAMI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), FAMI has stronger fundamentals. FATE is rated STRONG SELL (92% confidence) while FAMI is rated SELL (95% confidence). This is not investment advice.
How does FATE compare to FAMI fundamentally?
FATE THERAPEUTICS INC has ROE of -65.8% vs Farmmi, Inc.'s N/A. Net margins are -2,051.1% vs N/A respectively.
Which stock pays higher dividends, FATE or FAMI?
FATE has a dividend yield of N/A or no dividend while FAMI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in FATE or FAMI for long term?
For long-term investing, consider that FATE has STRONG SELL rating with 92% confidence, while FAMI has SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about FATE vs FAMI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For FATE vs FAMI, the AI consensus favors FAMI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.